drugset / Trial / NCT06020118
Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza Vaccinations
Phase 4
Completed
455 enrolled
Duke University
Arizona State University · collabCenters for Disease Control and Prevention · collabCleveland VA Medical Center · collabSenders Pediatrics · collabUniversity Hospitals Cleveland Medical Center · collabUniversity of Pittsburgh · collabValleywise Health · collabWashington University School of Medicine · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
This is a prospective, randomized randomized immunologic study of response to influenza and SARS-CoV-2 vaccination across four of the US Influenza Vaccine Effectiveness (Flu VE) Network study sites.
Timeline
- Start
- 2023-09-25
- Primary completion
- 2024-03-07
- Completion
- 2024-05-17